Earnings Feed
Start Free
ProQR Therapeutics N.V.·4

Jul 8, 2:55 PM ET

de Boer Daniel Anton 4

Research Summary

AI-generated summary

Updated

ProQR (PRQR) CEO Daniel de Boer Buys 150,000 Shares

What Happened
Daniel Anton de Boer, CEO of ProQR Therapeutics N.V. (PRQR), acquired 150,000 shares in an open-market purchase on July 7, 2026, at $1.59 per share, for a total cost of $238,500. This was a direct purchase (transaction code P), which is a straightforward insider buy rather than a sale or option exercise.

Key Details

  • Transaction date: 2026-07-07; reported on Form 4 filed 2026-07-08 (timely filing).
  • Transaction type: Open-market purchase (Code P).
  • Shares acquired: 150,000 at $1.59 per share.
  • Total value: $238,500.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes/plans: None disclosed in the provided excerpt (no 10b5-1 plan or tax withholding noted).

Context
Insider purchases are often viewed as a positive signal because executives are buying company stock with personal funds, but they are only one data point and do not guarantee future performance. This filing reports a straightforward buy (not an option exercise, gift, or award).